[1]
Rada, F.H. 2018. ANTIPLATELET ADEQUACY OF CYCLOPENTYL TRIAZOLOPYRIMIDINE VERSUS CLOPIDOGREL IN-PATIENTS WITH CORONARY HEART DISEASE. Asian Journal of Pharmaceutical and Clinical Research. 11, 12 (Dec. 2018), 536–539. DOI:https://doi.org/10.22159/ajpcr.2018.v11i12.29703.